Cargando…

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer remains a clinical challenge with considerable mortality. Circulating tumor DNA (ctDNA) has been suggested as a prognostic biomarker and enables the longitudinal evaluation of a patient’s disease and response to treatment. However, the role of ctDNA in treatment monito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faaborg, Louise, Andersen, Rikke Fredslund, Waldstrøm, Marianne, Henriksen, Jon Røikjær, Adimi, Parvin, Jakobsen, Anders, Steffensen, Karina Dahl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997085/ https://www.ncbi.nlm.nih.gov/pubmed/35406538 http://dx.doi.org/10.3390/cancers14071766

Ejemplares similares

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
por: Wen, Sara Witting Christensen, et al.
Publicado: (2021)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab
por: Andersen, Line Bechsgaard, et al.
Publicado: (2022)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
por: Brenner Thomsen, Caroline, et al.
Publicado: (2022)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling
por: Petersen, Annabeth Høgh, et al.
Publicado: (2016)

Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group
por: Callesen, Louise Bach, et al.
Publicado: (2023)

The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms
por: Abildgaard, Cecilie, et al.
Publicado: (2022)

Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022)

Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2017)

NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer
por: Raunkilde, Louise, et al.
Publicado: (2022)

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer
por: Thomsen, Caroline Emilie B., et al.
Publicado: (2017)

Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis
por: Borg, Morten, et al.
Publicado: (2023)

Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023)

Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
por: Borg, Morten, et al.
Publicado: (2022)

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
por: Sørensen, Patricia Diana, et al.
Publicado: (2015)

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer()
por: Hansen, Torben Frøstrup, et al.
Publicado: (2019)

Proactive use of PROMs in ovarian cancer survivors: a systematic review
por: Kargo, Anette Stolberg, et al.
Publicado: (2019)

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
por: Wen, Sara Witting Christensen, et al.
Publicado: (2023)

The Homeobox Only Protein Homeobox (HOPX) and Colorectal Cancer
por: Yamashita, Keishi, et al.
Publicado: (2013)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
por: Thomsen, Caroline B., et al.
Publicado: (2020)

Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG
por: Zhao, Huan, et al.
Publicado: (2021)

Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes
por: Chen, Buze, et al.
Publicado: (2022)

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer
por: Jensen, Lars Henrik, et al.
Publicado: (2019)

The challenge of involving old patients with polypharmacy in their medication during hospitalization in a medical emergency department: An ethnographic study
por: Fabricius, Pia Keinicke, et al.
Publicado: (2021)

Development of a Patient Decision Aid to Support Shared Decision Making for Patients with Recurrent High-Grade Glioma
por: Sorensen von Essen, Helle, et al.
Publicado: (2022)

Shared decision making in recurrent ovarian cancer: Implementation of patient decision aids across three departments of oncology in Denmark
por: Wulff, Christian Nielsen, et al.
Publicado: (2022)

Predicting brain metastases of breast cancer based on serum S100B and serum HER2
por: BECHMANN, TROELS, et al.
Publicado: (2013)

Shared decision making when patients consider surgery for lumbar herniated disc: development and test of a patient decision aid
por: Andersen, Stina Brogård, et al.
Publicado: (2019)

Homeobox Genes and Hepatocellular Carcinoma
por: Liu, Kwei-Yan, et al.
Publicado: (2019)

Genetics of Female Infertility: Molecular Study of Newborn Ovary Homeobox Gene in Poor Ovarian Responders
por: Batiha, Osamah, et al.
Publicado: (2019)

The homeobox gene TGIF1 is required for chicken ovarian cortical development and generation of the juxtacortical medulla
por: Estermann, Martin Andres, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7oa51trgd0nbq093be17k8f8o7